Ventas, Inc. (NYSE:VTR – Get Free Report) Director Michael Embler purchased 2,500 shares of the business’s stock in a transaction on Wednesday, June 3rd. The shares were bought at an average cost of $78.81 per share, with a total value of $197,025.00. Following the acquisition, the director directly owned 19,202 shares of the company’s stock, valued at $1,513,309.62. This trade represents a 14.97% increase in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.
Ventas Stock Performance
NYSE:VTR traded up $3.03 during mid-day trading on Friday, hitting $82.13. 3,615,209 shares of the company traded hands, compared to its average volume of 3,599,845. The stock’s fifty day moving average price is $85.06 and its 200-day moving average price is $82.36. Ventas, Inc. has a one year low of $61.76 and a one year high of $91.06. The company has a quick ratio of 0.25, a current ratio of 0.25 and a debt-to-equity ratio of 0.95. The firm has a market cap of $39.93 billion, a price-to-earnings ratio of 149.33, a price-to-earnings-growth ratio of 1.74 and a beta of 0.71.
Ventas (NYSE:VTR – Get Free Report) last released its quarterly earnings results on Monday, April 27th. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.12 by ($0.01). Ventas had a net margin of 4.25% and a return on equity of 2.09%. The company had revenue of $1.65 billion for the quarter, compared to the consensus estimate of $1.59 billion. During the same period in the prior year, the firm posted $0.84 EPS. The business’s revenue for the quarter was up 22.0% on a year-over-year basis. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. Research analysts anticipate that Ventas, Inc. will post 3.88 earnings per share for the current fiscal year.
Ventas Announces Dividend
Analyst Upgrades and Downgrades
Several research analysts have weighed in on VTR shares. BMO Capital Markets restated an “outperform” rating and issued a $100.00 price target on shares of Ventas in a research note on Monday, May 4th. Morgan Stanley set a $90.00 target price on shares of Ventas in a report on Friday, February 13th. Evercore restated an “outperform” rating and set a $95.00 target price on shares of Ventas in a research report on Wednesday, April 29th. The Goldman Sachs Group reiterated a “buy” rating and issued a $110.00 price target on shares of Ventas in a report on Tuesday, May 19th. Finally, UBS Group boosted their price target on shares of Ventas from $85.00 to $93.00 and gave the stock a “neutral” rating in a research note on Monday, May 4th. Fourteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $95.19.
Check Out Our Latest Research Report on Ventas
Hedge Funds Weigh In On Ventas
Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. BI Asset Management Fondsmaeglerselskab A S lifted its stake in shares of Ventas by 97.7% in the 3rd quarter. BI Asset Management Fondsmaeglerselskab A S now owns 36,713 shares of the real estate investment trust’s stock valued at $2,570,000 after purchasing an additional 18,146 shares during the last quarter. Vanguard Group Inc. lifted its stake in shares of Ventas by 2.5% in the 3rd quarter. Vanguard Group Inc. now owns 73,598,827 shares of the real estate investment trust’s stock valued at $5,151,182,000 after purchasing an additional 1,802,515 shares during the last quarter. Schroder Investment Management Group lifted its stake in shares of Ventas by 3.6% in the 3rd quarter. Schroder Investment Management Group now owns 2,487,572 shares of the real estate investment trust’s stock valued at $170,946,000 after purchasing an additional 85,340 shares during the last quarter. Krilogy Financial LLC bought a new stake in shares of Ventas in the 3rd quarter valued at approximately $919,000. Finally, Aberdeen Group plc lifted its stake in shares of Ventas by 8.3% in the 3rd quarter. Aberdeen Group plc now owns 1,580,923 shares of the real estate investment trust’s stock valued at $109,985,000 after purchasing an additional 120,825 shares during the last quarter. 94.18% of the stock is owned by institutional investors.
Ventas Company Profile
Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.
Ventas’ business model combines property ownership with active asset management and capital markets activity.
Read More
- Five stocks we like better than Ventas
- AI Server Earnings: Wall Street Sees One Clear Standout
- Navitas: NVIDIA’s AI Power Broker?
- A Lulu of a Miss Sends Lululemon to New Lows—Look Out Below
- NVIDIA’s New Power Play: Why Fluence Is Surging
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.
